MedTrace Logo

Prostate Impendance Test Project

NCT03428087 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-02-19

No results posted yet for this study

Summary

Impedance-based analysis could provide an adequate response to the need to identify a safe and reliable tool alternative to bioptic diagnosis. Patients who are candidates for prostate biopsy as suffering from urinary symptoms accompanied by clinical suspicions such as high total PSA value and / or presence of prostate nodule and / or evidence of obvious lesion to available imaging methods will be subjected to impedance measurement. Aim of this study is to be able to structure a bivariate analysis of the distribution of impedances detected in patients with neoplasia in order to detect test median reference values.

Conditions

  • Prostatic Neoplasms
  • PSA
  • Prostatic Biopsy
  • Impedance Test

Sponsors & Collaborators

  • University of Pisa

    lead OTHER

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-02-02
Completion
2018-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03428087 on ClinicalTrials.gov